跳至主要内容
临床试验/NCT03019471
NCT03019471招募中不适用

Non Invasive Cancer Test (NICT): a Proof of Principle Study.

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
ctDNA

研究概览

简要总结

The investigators aim to collect tumor DNA out of blood of cancer patients. If this is successful this could lead to the development of a cancer test in blood in the future, which is less invasive than current diagnostic methods.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with newly diagnosed local or metastatic breast cancer, colorectal cancer, non-small cell lung cancer and anaplastic glioblastoma, before start of radiation therapy, chemoradiation or chemotherapy.
  • Patients age > 18 years, willing and able to comply with the protocol as judged by the investigator with a signed informed consent

排除标准

  • Patients with a history of malignant disease other than the disease under study, with an exception for adequately treated squamous cell carcinoma of the skin, basal cell carcinoma of the skin and in situ cervix carcinoma.

结局指标

主要结局

ctDNA

时间窗: One year

Demonstrate the presence or absence of ctDNA in patients plasma. Examine if there us a sufficient concentration of ctDNA in the plasma to reliably diagnose cancer and determine the CNV

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Non Invasive Cancer Test (NICT): a Proof of... | 临床试验